Drug intelligence / Profile preview

meclizine

Development stage
Approved
Lead developer
Casper Pharma
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Meclizine is a piperazine-derivative antihistamine classified as an anticholinergic antiemetic. It is primarily used to prevent and treat nausea, vomiting, and dizziness associated with motion sickness and to manage vertigo caused by diseases affecting the vestibular system. Meclizine acts as a histamine H1 receptor antagonist with additional anticholinergic and central nervous system depressant properties. Its mechanism of action involves depressing labyrinth excitability and conduction in vestibular-cerebellar pathways[5][7]. The drug is available in oral tablet forms (including chewable) for adults and children aged 12 years or older[3]. Developed by Pfizer.

Brand names
AntivertBonineBonine MaxDramamine Less DrowsyDramamine Nausea Long LastingAntrizineTravel-Ease
Other names
meclizine hydrochloride
02

Targets

mAChR (Muscarinic acetylcholine receptors)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on meclizine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on meclizine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call